| Authors: |
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Follmann D; National Institute of Allergy and Infectious Diseases and Biostatistics Research Branch, National Institutes of Health, Bethesda, MD, United States of America., Nason M; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Mehrotra DV; Merck Research Laboratories, North Wales, PA, United States of America., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Metch B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Keefer MC; Infectious Disease Division, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America., Churchyard G; Aurum Institute for Health Research, Johannesburg, South Africa., Robb ML; HJF HIV Program, US Military HIV Research Program, Bethesda, MD, United States of America., Fast PE; Research and Development, International AIDS Vaccine Initiative, New York, New York, United States of America., Duerr A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America., Graham BS; Viral Pathogenesis Laboratory, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America., Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University, New York, New York, United States of America., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Robertson M; Infectious Disease Clinical Research, Merck, Philadelphia, Pennsylvania, United States of America., Hammer SM; Division of Infectious Diseases, Department of Medicine, Columbia University, New York, New York, United States of America., Gray GE; University of the Witwatersrand, Johannesburg, South Africa., Buchbinder SP; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. |
